MG-1102
Product Specifications
UNSPSC Description
MG-1102 is first-in-class dual binder of monomeric tau and pre-miRNA-146a. MG-1102 shows specific inhibition of miRNA146a with IC50s of 0.21 mM and 0.36 mM specific inhibition of doublelabeled pre-miRNA146a and mono-labeled pre-miRNA146a, respectively. MG-1102 interacts with tau monomers with a Kd of 3.21 mM by surface plasmon resonance (SPR). MG-1102 is a potential multi-target-directed ligands (MTDLs) for Alzheimer’s disease (AD)[1].
Target Antigen
MicroRNA; Tau Protein
Type
Reference compound
Related Pathways
Epigenetics;Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/mg-1102.html
Solubility
10 mM in DMSO
Smiles
COC1=CC(C=CC(C2=NNC=C2CN3C=CC=C3C4=NC=CS4)=C5)=C5C=C1
Molecular Weight
386.47
References & Citations
[1]Moustafa T. Gabr, et al. First dual binder of microRNA-146a and monomeric tau: a novel approach for multitargeted therapeutics for neurodegenerative diseases. Barbault, Chem. Commun., 2020
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-160481/MG-1102-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-160481/
Clinical Information
Phase 1
CAS Number
2567913-75-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
